The DOI matches its Crossref record.
Clostridial Toxins as Therapeutic Agents: Benefits of Nature's Most Toxic Proteins
Abstract
▪ Abstract Toxins are increasingly being used as valuable tools for analysis of cellular physiology, and some are used medicinally for treatment of human diseases. In particular, botulinum toxin, the most poisonous biological substance known, is used for treatment of a myriad of human neuromuscular disorders characterized by involuntary muscle contractions. Since approval of type-A botulinum toxin by the US Food and Drug Administration in December 1989 for three disorders (strabismus, blepharospasm, and hemifacial spasm), the number of indications being treated has increased greatly to include numerous focal dystonias, spasticity, tremors, cosmetic applications, migraine and tension headaches, and other maladies. Many of these diseases were previously refractory to pharmacological and surgical treatments. The remarkable therapeutic utility of botulinum toxin lies in its ability to specifically and potently inhibit involuntary muscle activity for an extended duration. The clostridia produce more protein toxins than any other bacterial genus and are a rich reservoir of toxins for research and medicinal uses. Research is underway to use clostridial toxins or toxin domains for drug delivery, prevention of food poisoning, and the treatment of cancer and other diseases. The remarkable success of botulinum toxin as a therapeutic agent has created a new field of investigation in microbiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
SV2 Is the Protein Receptor for Botulinum Neurotoxin A
Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R., & Chapman, E. R. (2006) · Science · doi:10.1126/science.1123654 · Cited by 770
Self-citationLong-Distance Retrograde Effects of Botulinum Neurotoxin A
Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., & Caleo, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0375-08.2008 · Cited by 450
Botulinum and tetanus neurotoxins: structure, function and therapeutic utility
Turton, K., Chaddock, J. A., & Acharya, K. R. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02177-1 · Cited by 348
Identification and characterization of a novel botulinum neurotoxin
Zhang, S., Masuyer, G., Zhang, J., Shen, Y., Lundin, D., Henriksson, L., Miyashita, S.-I., Martínez-Carranza, M., Dong, M., & Stenmark, P. (2017) · Nature Communications · doi:10.1038/ncomms14130 · Cited by 259
A synthetic hexapeptide (Argireline) with antiwrinkle activity
Blanes‐Mira, C., Clemente, J., Jodas, G., Gil, A., Fernández‐Ballester, G., Ponsati, B., Gutierrez, L., Pérez‐Payá, E., & Ferrer‐Montiel, A. (2002) · International Journal of Cosmetic Science · doi:10.1046/j.1467-2494.2002.00153.x · Cited by 187
Metadata
- Authors
- Johnson, E. A.
- Venue
- Annual Review of Microbiology
- Publisher
- Annual Reviews
- Published
- 1999-10
- Volume
- 53
- Issue
- 1
- Pages
- 551-575
- ISSN
- 0066-4227 (ISSN-L)
- 1545-3251
- OpenAlex
- W2089457319
- Cited by
- 173
- References
- 0
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clostridial Toxins as Therapeutic Agents: Benefits of Nature's Most Toxic Proteins. https://app.cochat.ai/papers/10.1146/annurev.micro.53.1.551
- The paper
- Johnson, E. A. (1999). Clostridial Toxins as Therapeutic Agents: Benefits of Nature's Most Toxic Proteins. Annual Review of Microbiology. https://doi.org/10.1146/annurev.micro.53.1.551
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.